The prestigious medical center Georgetown University at Washington DC has sign a contract with ISK to run a clinical trial with patients with mtKRAS pancreas and colon cancers.
Recent Posts
- Phase II update – A second patient (92 years old) had a strong reduction in blasts in the bone marrow
- Update from AML human trial in Miami
- Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors
- PHASE 1B/2A Clinical trial started
- ISK received the FDA’s approval to start Phase 1b/2a with AML patients